<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Sci Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id>
<journal-title-group>
<journal-title>Scientific Reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2045-2322</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29343763</article-id>
<article-id pub-id-type="pmc">5772371</article-id>
<article-id pub-id-type="publisher-id">19156</article-id>
<article-id pub-id-type="doi">10.1038/s41598-018-19156-w</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Association of <italic>S100B</italic> polymorphisms and serum S100B with risk of ischemic stroke in a Chinese population</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Lu</surname>
<given-names>Yu-Lan</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wang</surname>
<given-names>Rong</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Hua-Tuo</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qin</surname>
<given-names>Hai-Mei</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Chun-Hong</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiang</surname>
<given-names>Yang</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Chun-Fang</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luo</surname>
<given-names>Hong-Cheng</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Jun-Li</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lan</surname>
<given-names>Yan</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wei</surname>
<given-names>Ye-Sheng</given-names>
</name>
<address>
<email>yeshengwei22@163.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.460081.b</institution-id><institution>Department of Clinical Laboratory, </institution><institution>Affiliated Hospital of Youjiang Medical University for Nationalities, No.18 Zhongshan Road II, </institution></institution-wrap>Baise, 533000 Guangxi China </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.460081.b</institution-id><institution>Department of Dermatology, </institution><institution>Affiliated Hospital of Youjiang Medical University for Nationalities, No.18 Zhongshan Road II, </institution></institution-wrap>Baise, 533000 Guangxi China </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>17</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>17</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>8</volume>
<elocation-id>971</elocation-id>
<history>
<date date-type="received">
<day>31</day>
<month>5</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>12</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">The levels of serum S100B were elevated in patients with ischemic stroke (IS), which may be a novel biomarker for diagnosing IS. The aim of this study was to investigate the association of <italic>S100B</italic> polymorphisms and serum S100B with IS risk. We genotyped the <italic>S100B</italic> polymorphisms rs9722, rs9984765, rs2839356, rs1051169 and rs2186358 in 396 IS patients and 398 controls using polymerase chain reaction-single base extension (SBE-PCR). Serum S100B levels were measured by enzyme-linked immunosorbent assay (ELISA). Rs9722 was associated with an increased risk of IS (AA vs. GG: adjusted OR = 2.172, 95% CI, 1.175–4.014, <italic>P</italic> = 0.013; dominant: adjusted OR = 1.507, 95% CI, 1.071–2.123, <italic>P</italic> = 0.019; recessive: adjusted OR = 1.846, 95% CI, 1.025–3.323, <italic>P</italic> = 0.041; additive: adjusted OR=1.371, 95% CI, 1.109-1.694, P = 0.003). The A-C-C-C-A haplotype was associated with an increased risk of IS (OR = 1.325, 95% CI, 1.035–1.696, <italic>P</italic> = 0.025). In addition, individuals carrying the rs9722 GA/AA genotypes had a higher serum S100B compared with the rs9722 GG genotype in IS patients (<italic>P</italic> = 0.018). Our results suggest that the <italic>S100B</italic> gene rs9722 polymorphism may contribute to the susceptibility of IS, probably by promoting the expression of serum S100B.</p>
</abstract>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p id="Par2">Stroke is a multi-factorial disease that constitutes one of the leading causes of adult disability worldwide<sup><xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR3">3</xref></sup>. In recent years, the incidence of stroke has increased dramatically in China<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. Approximately 80% of strokes are ischemic in origin. Ischemic stroke (IS) is the result of interrupted blood flow within the area of an occluded blood vessel, causing local brain tissue to become deprived of oxygen, ending in malacia and necrosis. Several risk factors have been identified to contribute to the pathogenesis of IS, including age, gender, obesity, hypertension, diabetes, smoking and dyslipidaemia<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. However, these conventional risk factors do not fully account for the overall risk of IS. Several lines of evidence have indicated that genetic factors are also involved in the development of IS<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR7">7</xref></sup>. To date, the possible relationship of IS with altered transcription of genes has not been ruled out.</p>
<p id="Par3">S100 calcium-binding protein B (S100B) belongs to the large superfamily of S100, which is mainly expressed by astrocytes in the brain and plays a crucial role in cell proliferation, differentiation, apoptosis, signal transduction, cellular energy and metabolism<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>. Furthermore, by interacting with the receptor for advanced glycation end products (RAGE), S100B can activate microglial cells and stimulate the secretion of inflammatory cytokines, such as tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and the chemokine 22 (CCL22), and upregulate the expression of the proinflammatory enzyme COX-2<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup>. These cytokines have been previously reported to play a role in the pathogenesis of IS<sup><xref ref-type="bibr" rid="CR12">12</xref>–<xref ref-type="bibr" rid="CR16">16</xref></sup>. More recently, increasing evidence has identified that serum S100B levels may be used as a potential biomarker for cardiovascular diseases<sup><xref ref-type="bibr" rid="CR17">17</xref>–<xref ref-type="bibr" rid="CR22">22</xref></sup>. In addition, evidence from clinical studies and animal models have suggested that elevated levels of serum S100B play a vital role in the development of IS<sup><xref ref-type="bibr" rid="CR23">23</xref>–<xref ref-type="bibr" rid="CR26">26</xref></sup>. Taken together, these findings indicate that S100B may represent a promising candidate for the treatment of IS.</p>
<p id="Par4">Single nucleotide polymorphisms (SNPs) are the most common variants in human genomes and have been used frequently as genetic markers in genome-wide association studies (GWAS)<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. The human <italic>S100B</italic> gene is located on chromosome 21q22.3, which consists of 3 exons and 2 introns. Previously, a number of studies have indicated that <italic>S100B</italic> polymorphisms may modulate an individual’s susceptibility to several human diseases, such as schizophrenia, dyslexia, autism and bipolar affective disorder<sup><xref ref-type="bibr" rid="CR28">28</xref>–<xref ref-type="bibr" rid="CR31">31</xref></sup>. However, to our knowledge, no study has investigated the associations between <italic>S100B</italic> polymorphisms and IS susceptibility. Therefore, the aim of this study was to investigate the association of the five SNPs in the <italic>S100B</italic> gene with susceptibility to IS in a Chinese population. Moreover, the effect of <italic>S100B</italic> polymorphisms on the levels of serum S100B was also assessed.</p>
</sec>
<sec id="Sec2" sec-type="results">
<title>Results</title>
<sec id="Sec3">
<title>Clinical characteristics of the study participants</title>
<p id="Par5">The clinical characteristics of IS patients and controls are summarized in Table <xref ref-type="table" rid="Tab1">1</xref>. There were no significant differences between the two groups based on age, gender and TCH (<italic>P</italic> &gt; 0.05). The frequencies of hypertension, diabetes mellitus and smoker in IS patients were significantly higher than those in controls (<italic>P</italic> &lt; 0.05). Increased levels of TG, LDL-C, VLDL-C and lower levels of HDL-C were observed in IS patients compared with controls (<italic>P</italic> &lt; 0.001).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Clinical characteristics of the study population.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Variables</th><th>Controls (n = 398)</th><th>IS patients (n = 396)</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td>Age, years (mean ± SD)</td><td>58.09 ± 8.76</td><td>59.16 ± 9.18</td><td>0.093</td></tr><tr><td>Gender (M/F)</td><td>231/167</td><td>252/144</td><td>0.106</td></tr><tr><td>Hypertension, n (%)</td><td>88 (22.1%)</td><td>161 (40.6%)</td><td>&lt;0.001</td></tr><tr><td>Diabetes mellitus, n (%)</td><td>41 (10.3%)</td><td>64 (16.2%)</td><td>0.015</td></tr><tr><td>Smoker, n (%)</td><td>62 (15.6%)</td><td>116 (29.3%)</td><td>&lt;0.001</td></tr><tr><td>TCH, mmol/L</td><td>4.84 ± 0.74</td><td>4.78 ± 1.23</td><td>0.390</td></tr><tr><td>TG, mmol/L</td><td>1.24 ± 0.74</td><td>1.60 ± 1.09</td><td>&lt;0.001</td></tr><tr><td>HDL-C, mmol/L</td><td>1.66 ± 0.39</td><td>1.26 ± 0.35</td><td>&lt;0.001</td></tr><tr><td>LDL-C, mmol/L</td><td>2.47 ± 0.56</td><td>2.64 ± 0.89</td><td>&lt;0.001</td></tr><tr><td>VLDL-C, mmol/L</td><td>0.57 ± 0.36</td><td>0.73 ± 0.49</td><td>&lt;0.001</td></tr></tbody></table><table-wrap-foot><p>IS, ischemic stroke; SD, standard deviation; M, male; F, female; TCH, total cholesterol; TG, triglyceride; HDL-C, high density lipoprotein-cholesterol; LDL-C, low density lipoprotein-cholesterol; VLDL-C, very low density lipoprotein-cholesterol.</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec4">
<title>Association of <italic>S100B</italic> polymorphisms with IS risk</title>
<p id="Par6">All five SNP genotypes were in HWE among control subjects (<italic>P</italic> &gt; 0.05). The association between <italic>S100B</italic> polymorphisms and risk of IS under genotype and genetics models analysis are shown in Table <xref ref-type="table" rid="Tab2">2</xref>. We observed that the rs9722 AA genotype was associated with an increased risk of IS compared with the GG genotype, even after adjusting for age, gender, hypertension, diabetes mellitus, smoker, TCH, TG, HDL-C, LDL-C and VLDL-C (AA vs. GG: adjusted OR = 2.172, 95% CI, 1.175–4.014, <italic>P</italic> = 0.013). Similarly, a significantly increased risk was also observed in the dominant model (GA/AA vs. GG: adjusted OR = 1.507, 95% CI, 1.071–2.123, <italic>P</italic> = 0.019), recessive model (AA vs. GA/GG: adjusted OR = 1.846, 95% CI, 1.025–3.323, <italic>P</italic> = 0.041) and additive model (A vs. G: adjusted OR=1.371, 95% CI, 1.109-1.694, P = 0.003). However, after correction for multiple comparisons, all associations described above lost statistical significance. Studies with greater sample sizes are needed to confirm these associations.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Association between the <italic>S100B</italic> polymorphisms and risk of IS.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>SNPs</th><th>Controls (n = 398)</th><th>IS patients (n = 396)</th><th>AOR (95% CI)<sup>†</sup></th><th>
<italic>P</italic>
<sup>†</sup>
</th><th>
<italic>P</italic>
<sub><italic>BH</italic></sub>
</th></tr></thead><tbody><tr><td colspan="6">
<bold>rs9722</bold>
</td></tr><tr><td>GG</td><td>197 (49.5)</td><td>163 (41.2)</td><td>1.000 (ref)</td><td></td><td></td></tr><tr><td>GA</td><td>175 (44.0)</td><td>186 (47.0)</td><td>1.392 (0.973–1.993)</td><td>0.071</td><td>0.213</td></tr><tr><td>AA</td><td>26 (6.5)</td><td>47 (11.9)</td><td>2.172 (1.175–4.014)</td><td>0.013</td><td>0.095</td></tr><tr><td>Dominant</td><td></td><td></td><td>1.507 (1.071–2.123)</td><td>0.019</td><td>0.095</td></tr><tr><td>Recessive</td><td></td><td></td><td>1.846 (1.025–3.323)</td><td>0.041</td><td>0.154</td></tr><tr><td>Additive</td><td></td><td></td><td>1.371 (1.109–1.694)</td><td>0.003</td><td>0.045</td></tr><tr><td colspan="6">
<bold>rs9984765</bold>
</td></tr><tr><td>TT</td><td>190 (47.7)</td><td>176 (44.4)</td><td>1.000 (ref)</td><td></td><td></td></tr><tr><td>CT</td><td>177 (44.5)</td><td>179 (45.2)</td><td>1.290 (0.902–1.845)</td><td>0.163</td><td>0.348</td></tr><tr><td>CC</td><td>31 (7.8)</td><td>41 (10.4)</td><td>1.497 (0.817–2.743)</td><td>0.192</td><td>0.348</td></tr><tr><td>Dominant</td><td></td><td></td><td>1.325 (0.941–1.864)</td><td>0.107</td><td>0.268</td></tr><tr><td>Recessive</td><td></td><td></td><td>1.320 (0.740–2.354)</td><td>0.347</td><td>0.377</td></tr><tr><td>Additive</td><td></td><td></td><td>1.146 (0.927–1.416)</td><td>0.209</td><td>0.348</td></tr><tr><td colspan="6">
<bold>rs2839356</bold>
</td></tr><tr><td>TT</td><td>196 (49.2)</td><td>182 (46.0)</td><td>1.000 (ref)</td><td></td><td></td></tr><tr><td>CT</td><td>174 (43.7)</td><td>178 (44.9)</td><td>1.194 (0.837–1.703)</td><td>0.327</td><td>0.377</td></tr><tr><td>CC</td><td>28 (7.1)</td><td>36 (9.1)</td><td>1.080 (0.574–2.032)</td><td>0.812</td><td>0.508</td></tr><tr><td>Dominant</td><td></td><td></td><td>1.175 (0.837–1.650)</td><td>0.352</td><td>0.377</td></tr><tr><td>Recessive</td><td></td><td></td><td>0.992 (0.539–1.824)</td><td>0.979</td><td>0.587</td></tr><tr><td>Additive</td><td></td><td></td><td>1.115 (0.900–1.382)</td><td>0.320</td><td>0.377</td></tr><tr><td colspan="6">
<bold>rs1051169</bold>
</td></tr><tr><td>GG</td><td>164 (41.2)</td><td>153 (38.6)</td><td>1.000 (ref)</td><td></td><td></td></tr><tr><td>CG</td><td>178 (44.7)</td><td>186 (47.0)</td><td>1.149 (0.795–1.660)</td><td>0.460</td><td>0.406</td></tr><tr><td>CC</td><td>56 (14.1)</td><td>57 (14.4)</td><td>1.152 (0.684–1.942)</td><td>0.595</td><td>0.406</td></tr><tr><td>Dominant</td><td></td><td></td><td>1.150 (0.812–1.627)</td><td>0.432</td><td>0.406</td></tr><tr><td>Recessive</td><td></td><td></td><td>1.069 (0.660–1.731)</td><td>0.787</td><td>0.508</td></tr><tr><td>Additive</td><td></td><td></td><td>1.064 (0.868–1.304)</td><td>0.551</td><td>0.406</td></tr><tr><td colspan="6">
<bold>rs2186358</bold>
</td></tr><tr><td>AA</td><td>328 (82.4)</td><td>336 (84.8)</td><td>1.000 (ref)</td><td></td><td></td></tr><tr><td>AC</td><td>63 (15.8)</td><td>56 (14.2)</td><td>0.876 (0.549–1.398)</td><td>0.579</td><td>0.406</td></tr><tr><td>CC</td><td>7 (1.8)</td><td>4 (1.0)</td><td>0.608 (0.130–2.857)</td><td>0.529</td><td>0.406</td></tr><tr><td>Dominant</td><td></td><td></td><td>0.853 (0.543–1.340)</td><td>0.490</td><td>0.406</td></tr><tr><td>Recessive</td><td></td><td></td><td>0.621 (0.132–2.910)</td><td>0.545</td><td>0.406</td></tr><tr><td>Additive</td><td></td><td></td><td>0.821 (0.580–1.162)</td><td>0.265</td><td>0.377</td></tr></tbody></table><table-wrap-foot><p>IS, ischemic stroke; OR, odds ratio; 95% CI, 95% confidence interval. <sup>†</sup>Adjusted by age, gender, hypertension, diabetes mellitus, smoker, TCH, TG, HDL-C, LDL-C and VLDL-C. P<sub>BH</sub>: <italic>P</italic> values corrected by Benjamin-Hochberg (B-H) method.</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec5">
<title>Distribution of the <italic>S100B</italic> gene rs9722 polymorphism in different populations</title>
<p id="Par7">Because rs9722 may play an important role in the development of IS, we then performed a comparison of the genotype distribution of rs9722 in different populations (Table <xref ref-type="table" rid="Tab3">3</xref><bold>)</bold>. The results showed that the genotype distribution of rs9722 in our study was significantly different compared with HM-HCB, HM-JPT, HM-CEU, HM-YRI, HM-ASW, HM-LWK, HM-MEX, HM-MKK and HM-TSI (<italic>P</italic> &lt; 0.05). However, no significant difference was found when comparing with HM-CHB, HM-CHD and HM-GIH (<italic>P</italic> &gt; 0.05).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Distribution of the rs9722 polymorphism in different populations.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Group</th><th rowspan="2">N</th><th colspan="3">Genotype (%)</th><th colspan="2">Allele (%)</th><th rowspan="2">Ethnicity</th></tr><tr><th>GG</th><th>GA</th><th>AA</th><th>G</th><th>A</th></tr></thead><tbody><tr><td>Our data</td><td>398</td><td>197 (49.5)</td><td>175 (44.0)</td><td>26 (6.5)</td><td>569 (71.5)</td><td>227 (28.5)</td><td>Guangxi</td></tr><tr><td>HM-CHB</td><td>82</td><td>46 (56.1)</td><td>26 (31.7)</td><td>10 (12.2)</td><td>118 (72.0)</td><td>46 (28.0)</td><td>Asian</td></tr><tr><td>HM-HCB<sup>*</sup></td><td>84</td><td>26 (30.9)</td><td>44 (52.4)</td><td>14 (16.7)</td><td>96 (57.1)</td><td>72 (42.9)</td><td>Asian</td></tr><tr><td>HM-CHD</td><td>170</td><td>82 (48.2)</td><td>78 (45.9)</td><td>10 (5.9)</td><td>242 (71.2)</td><td>98 (28.8)</td><td>Asian</td></tr><tr><td>HM-JPT<sup>*</sup></td><td>172</td><td>60 (34.9)</td><td>98 (57.0)</td><td>14 (8.1)</td><td>218 (63.4)</td><td>126 (36.6)</td><td>Asian</td></tr><tr><td>HM-CEU<sup>*</sup></td><td>226</td><td>184 (81.4)</td><td>40 (17.7)</td><td>2 (0.9)</td><td>408 (90.3)</td><td>44 (9.7)</td><td>European</td></tr><tr><td>HM-YRI<sup>*</sup></td><td>226</td><td>46 (20.3)</td><td>124 (54.9)</td><td>56 (24.8)</td><td>216 (47.8)</td><td>236 (52.2)</td><td>African</td></tr><tr><td>HM-ASW<sup>*</sup></td><td>98</td><td>36 (36.7)</td><td>50 (51.0)</td><td>12 (12.3)</td><td>122 (62.2)</td><td>74 (37.8)</td><td>African</td></tr><tr><td>HM-GIH</td><td>174</td><td>90 (51.7)</td><td>72 (41.4)</td><td>12 (6.9)</td><td>252 (72.4)</td><td>96 (27.6)</td><td>Asian</td></tr><tr><td>HM-LWK<sup>*</sup></td><td>176</td><td>64 (36.4)</td><td>82 (46.6)</td><td>30 (17.0)</td><td>210 (59.7)</td><td>142 (40.3)</td><td>Asian</td></tr><tr><td>HM-MEX<sup>*</sup></td><td>100</td><td>78 (78.0)</td><td>22 (22.0)</td><td>—</td><td>178 (89.0)</td><td>22 (11.0)</td><td>America</td></tr><tr><td>HM-MKK<sup>*</sup></td><td>284</td><td>78 (27.5)</td><td>144 (50.7)</td><td>62 (21.8)</td><td>300 (52.8)</td><td>268 (47.2)</td><td>African</td></tr><tr><td>HM-TSI<sup>*</sup></td><td>176</td><td>154 (87.5)</td><td>20 (11.4)</td><td>2 (1.1)</td><td>328 (93.2)</td><td>24 (6.8)</td><td>European</td></tr></tbody></table><table-wrap-foot><p><sup>*</sup><italic>P</italic> &lt; 0.05 comparing with our present data; HM: Haplotype Map; CHB: Han Chinese in Beijing, China; HCB: Han Chinese in Beijing, China; CHD: Chinese in Metropolitan Denver, Colorado; JPT: Japanese in Tokyo, Japan; CEU: Utah residents with northern and western European ancestry; YRI: Yoruba in Ibadan, Nigeria; ASW: African ancestry in Southwest USA; GIH: Gujarati Indians in Houston, Texas; LWK: Luhya in Webuye, Kenya; MEX: Mexican ancestry in Los Angeles, California; MKK: Maasai in Kinyawa, Kenya; TSI: Toscans in Italy.</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec6">
<title>Haplotype analysis of the <italic>S100B</italic> gene</title>
<p id="Par8">Haplotype analysis was performed and the possible five haplotype frequencies are shown in Table <xref ref-type="table" rid="Tab4">4</xref>. The results showed that rs9984765 was in strong linkage disequilibrium (LD) with rs2839356 (D′ = 0.931) and rs1051169 (D′ = 0.882). Similarly, rs2839356 was in strong LD with rs1051169 (D′ = 0.852) and rs2186358 (D′ = 0.805). Moreover, we found that the A-C-C-C-A haplotype was associated with an increased risk of IS (OR = 1.325, 95% CI, 1.035–1.696, <italic>P</italic> = 0.025). The G-T-T-C-C haplotype was associated with a decreased risk of IS (OR = 0.480, 95% CI, 0.275–0.838, <italic>P</italic> = 0.008).<table-wrap id="Tab4"><label>Table 4</label><caption><p>Haplotype analysis of the <italic>S100B</italic> polymorphisms with risk of IS.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Haplotype</th><th>Controls (2n = 796)</th><th>IS patients (2n = 792)</th><th>OR (95% CI)</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td>G T T G A</td><td>414 (52.0)</td><td>385 (48.6)</td><td>0.899 (0.726–1.113)</td><td>0.329</td></tr><tr><td>A C C C A</td><td>152 (19.1)</td><td>183 (23.1)</td><td>1.325 (1.035–1.696)</td><td>0.025</td></tr><tr><td>G C C C A</td><td>47 (5.9)</td><td>41 (5.2)</td><td>0.891 (0.579–1.372)</td><td>0.600</td></tr><tr><td>A T T G A</td><td>46 (5.7)</td><td>51 (6.5)</td><td>1.163 (0.769–1.760)</td><td>0.474</td></tr><tr><td>G T T C C</td><td>40 (5.0)</td><td>19 (2.4)</td><td>0.480 (0.275–0.838)</td><td>0.008</td></tr></tbody></table><table-wrap-foot><p>IS, ischemic stroke; OR, odds ratio; 95% CI, 95% confidence interval.</p></table-wrap-foot></table-wrap></p>
</sec>
<sec id="Sec7">
<title>Association of <italic>S100B</italic> polymorphism and serum S100B levels</title>
<p id="Par9">We then investigated the association between <italic>S100B</italic> polymorphisms and serum S100B levels. As shown in Fig. <xref ref-type="fig" rid="Fig1">1</xref>, the levels of serum S100B were significantly up- regulated in IS patients compared with controls [(115.03 ± 44.42) pg/mL vs. (70.53 ± 30.98) pg/mL, <italic>P</italic> &lt; 0.001]. Notably, we found that patients carrying the rs9722 GA/AA genotypes had a higher expression of serum S100B compared with those carrying the rs9722 GG genotype [(123.98 ± 47.42) pg/mL vs. (101.33 ± 36.98) pg/mL, <italic>P</italic> = 0.018].<fig id="Fig1"><label>Figure 1</label><caption><p>ELISA detection of serum S100B levels. <bold>(A)</bold> There were significant differences in the levels of serum S100B between IS patients [(115.03 ± 44.42) pg/mL; n = 44] and controls [(70.53 ± 30.98) pg/mL; n = 44], (P &lt; 0.001). <bold>(B)</bold> Increased levels of serum S100B in IS patients carrying the rs9722 GA/AA genotypes [(123.98 ± 47.42) pg/mL; n = 52] compared with those carrying the rs9722 GG genotype [(101.33 ± 36.98) pg/mL; n = 36)], (<italic>P</italic> = 0.018). Data are presented as the mean ± standard error.</p></caption><graphic id="d29e1772" xlink:href="41598_2018_19156_Fig1_HTML"></graphic></fig></p>
</sec>
</sec>
<sec id="Sec8" sec-type="discussion">
<title>Discussion</title>
<p id="Par10">To our knowledge, this is the first report to determine whether <italic>S100B</italic> polymorphisms and the levels of serum S100B are associated with IS in the Chinese population. In this study, we observed that the rs9722 AA genotype, dominant model, recessive model and additive model were associated with significantly increased risk of IS. An increased risk was also observed in the haplotype analysis. Moreover, we found that the levels of serum S100B were significantly up-regulated in IS patients compared with controls. Interestingly, the rs9722 GA/AA genotypes corresponded to higher levels of serum S100B. The statistical power of the study was calculated to be 91% to detect the association between rs9722 polymorphism and IS risk in a sample size of 794 participants (396 IS patients and 398 controls), assuming an OR of 1.6 and α of 0.05 (PASS 15.0 software). Therefore, these findings indicate that the <italic>S100B</italic> gene rs9722 polymorphism may serve as a novel genetic marker of susceptibility to IS in the Chinese population.</p>
<p id="Par11">Stroke is one of the major causes of death and long-term disability worldwide. Globally, there are &gt;50 million stroke patients, producing an immense burden on the economic and healthcare infrastructure<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. To date, however, the exact aetiology and pathogenetic mechanisms of IS remain unclear. Recently, increasing evidence has indicated that serum S100B levels may be used as a novel biomarker for IS<sup><xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR35">35</xref></sup>. Nevertheless, the mechanisms leading to elevated serum S100B are unknown, but this is believed to lead to aggravation of the development of IS. In the present study, our results also showed that the levels of serum S100B in IS patients were significantly higher than in controls. The results of our study suggest that S100B may play a crucial role in the aetiology of IS.</p>
<p id="Par12">Recently, several studies have been conducted to investigate the effect of the rs9722 polymorphism on human diseases. Matsson <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR29">29</xref></sup> reported that the rs9722 polymorphism was associated with dyslexia, and the T allele was suggested as a risk factor for the development of dyslexia. Hohoff <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> found that the rs9722 AA genotype was significantly associated with the high expression of S100B in the prefrontal cortex or peripheral blood. Li <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR37">37</xref></sup> demonstrated that the rs9722 T allele was associated with the risk of severe hand, foot and mouth disease. Similarly, a case-control study conducted by Liu <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR38">38</xref></sup> reported that the rs1051169-rs9722 (G-C) haplotype may have a possible susceptibility to increase the expression of serum S100B. In contrast, Yang <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR39">39</xref></sup> showed that the rs9722 polymorphism was not correlated with the risk of major depressive disorder in a Chinese population. To date, no association study has been reported on the association between the rs9722 polymorphism and IS. However, in this study, we found that the rs9722 AA genotype, dominant, recessive and additive model display an increased risk of IS. Additionally, the levels of serum S100B were found to be elevated in IS patients. Interestingly, we observed that individuals carrying the rs9722 GA/AA genotypes had a higher serum S100B compared with the rs9722 GG genotype in IS patients. In summary, these results suggest that the <italic>S100B</italic> gene rs9722 polymorphism may be responsible for susceptibility to IS, probably through up-regulation of the expression of serum S100B.</p>
<p id="Par13">Until now, very limited data have been reported on the association of rs9984765, rs2839356 and rs2186358 polymorphisms with disease susceptibility. A previous study conducted by Hohoff <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> reported that the T-G-G-A (rs2186358-rs11542311-rs2300403-rs9722) haplotype was associated with elevated levels of serum S100B. Meanwhile, the G-A-T-C (rs11542311-rs2839356-rs9984765-rs881827) haplotype was associated with increased expression of <italic>S100B</italic> mRNA in postmortem frontal cortices. Regarding the rs1051169 polymorphism, Guo <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR40">40</xref></sup> have tried to detect the association of the rs1051169 polymorphism with Parkinson’s disease in a Chinese population, but failed to have a positive result. However, Liu <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR38">38</xref></sup> found that the rs1051169 polymorphism was associated with an increased risk of schizophrenia in the Chinese population.</p>
<p id="Par14">In the present study, we failed to find any association of the rs9984765, rs2839356, rs1051169 and rs2186358 polymorphisms with IS risk. Two possibilities should be taken into account to explain the negative results. First, it may be because of genetic trait differences, as we know that genetic polymorphisms in human genes are distinct in specific populations, various ethnicities and geographic regions. Data from Table <xref ref-type="table" rid="Tab5">5</xref> support this viewpoint, we observed that the genotype distribution of rs9722 in our study showed significant differences compared with the HM-HCB, HM-JPT, HM-CEU, HM-YRI, HM-ASW, HM-LWK, HM-MEX, HM-MKK and HM-TSI populations, but was similar to the HM-CHB, HM-CHD and HM-GIH populations. Secondly, stroke is a multi-factorial disease that is regulated by genetic and environmental factors; thus, individual exposure to different environmental factors and genetic susceptibility might have caused different results.<table-wrap id="Tab5"><label>Table 5</label><caption><p>The primer sequences used for detecting five SNPs of the <italic>S100B</italic> gene.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>SNP ID</th><th>Position</th><th>PCR primers</th></tr></thead><tbody><tr><td rowspan="3">rs9722</td><td rowspan="3">48019239</td><td>F: 5′-ACAACACGGCTGGAAAGCTCAG-3′</td></tr><tr><td>R: 5′-GATGGAGACGGCGAATGTGACT-3′</td></tr><tr><td>EF: 5′-TTTTTTTTTTTTTTTTTTGCCAAACCTTTCCTGTAACAGAGA-3′</td></tr><tr><td rowspan="3">rs9984765</td><td rowspan="3">48021655</td><td>F: 5′-CTCCACAGAGCCTCCTGCAAAG-3′</td></tr><tr><td>R: 5′-CCTGGCACATGGATGAATGACC-3′</td></tr><tr><td>EF: 5′-TTTTTTTTTTTTACCATGACTGGCTTAACTGAGG-3′</td></tr><tr><td rowspan="3">rs2839356</td><td rowspan="3">48022144</td><td>F: 5′-TCACCTTCAGGGCAGCTGAGAA-3′</td></tr><tr><td>R: 5′-TGGAAGGGAGGGAGACAAGCAC-3′</td></tr><tr><td>EF: 5′-TTTTTTTTTTTTTTTTTTTTTTTTAAGATAAAGCCAGTGTACAGATGGAT-3′</td></tr><tr><td rowspan="3">rs1051169</td><td rowspan="3">4802230</td><td>F: 5′-TCACCTTCAGGGCAGCTGAGAA-3′</td></tr><tr><td>R: 5′-TGGAAGGGAGGGAGACAAGCAC-3′</td></tr><tr><td>EF: 5′-TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTCACAAGCTGAAGAAATCCGAACT-3′</td></tr><tr><td rowspan="3">rs2186358</td><td rowspan="3">48022375</td><td>F: 5′-GACATCCTAGGGGCTCGCAAAG-3′</td></tr><tr><td>R: 5′-CCCCTTGTCTGGGTTGAGGTCT-3′</td></tr><tr><td>EF: 5′-TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTAGTTGCCTTCTCATCTATACCTCATC-3′</td></tr></tbody></table><table-wrap-foot><p>F: forward primer; R: reverse primer; EF: Extended primer.</p></table-wrap-foot></table-wrap></p>
<p id="Par15">S100B, produced mainly by activated astrocytes, has already been confirmed to participate in regulating cell proliferation, differentiation and apoptosis<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. Previous studies have indicated that extracellular S100B binds to its membrane receptor RAGE and then activates a series of cellular signalling pathways and leads to the production of TNF-α, IL-1β, IL-6 and VCAM-1<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR42">42</xref>,<xref ref-type="bibr" rid="CR43">43</xref></sup>. Serum levels of IL-1β and IL-6 were significantly increased in IS patients, with a function of promoting IS progression<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. TNF-α has been previously reported to play a key role in the pathogenesis of IS<sup><xref ref-type="bibr" rid="CR44">44</xref>,<xref ref-type="bibr" rid="CR45">45</xref></sup>. Cao <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR46">46</xref></sup> reported that S100B can promote vascular smooth muscle cell (VSMC) proliferation, causing neointimal formation, whereas secreted S100B from VSMCs may block re-endothelialisation and impair vascular repair. Beer <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR47">47</xref></sup> reported that serum-S100B was positively correlated with plasma high-sensitivity C-reactive protein. In addition, clinical and experimental studies have demonstrated that the levels of serum S100B were elevated in patients with IS<sup><xref ref-type="bibr" rid="CR33">33</xref>,<xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR48">48</xref></sup>. Furthermore, a previous study found that knockdown of S100B in atherosclerotic mice can improve the brain’s recovery function and reduced infarctions<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. Given the crucial role of S100B in IS pathogenesis, the positive results of our present study were biologically reasonable.</p>
<p id="Par16">There are several limitations in our study. First, the relatively small sample size may limit the statistical power of our study. Further large-scale studies still need to be performed. Second, because this is a hospital-based case-control study, we cannot rule out the possibility of selection bias. Finally, our study subjects are all Chinese; thus, the results cannot be directly applicable to other ethnic groups.</p>
<p id="Par17">In summary, our study provides evidence that the polymorphism of rs9722 in the <italic>S100B</italic> gene is associated with IS in the Chinese population. In the future, further studies with a larger sample size in diverse ethnic groups should be performed to confirm these findings.</p>
</sec>
<sec id="Sec9" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="Sec10">
<title>Study population</title>
<p id="Par18">The procedure was approved by the Review Boards of Affiliated Hospital of Youjiang Medical College for Nationalities. The study was performed in accordance with the relevant guidelines. All participators have written informed consent before participating in this study. The study subjects included 396 patients with IS and 398 controls. All IS patients were collected from the Department of Neurology, Affiliated Hospital of Youjiang Medical University for Nationalities, Guangxi, China between January 2013 and September 2016. IS was defined as a focal or global neurological deficit of sudden onset lasting more than 24 h caused by cerebral ischemia. All IS patients were diagnosed according to clinical symptoms, physical examination and cranial computed tomography (CT) or magnetic resonance imaging (MRI). Patients with haemorrhagic stroke, traumatic brain injuries, cardiogenic thrombosis and tumours were excluded in our study. The control subjects were selected from the Health Medical Center of the hospital during the same period. Individuals with tumours, autoimmune diseases, genetic disease, liver ailments and haematological diseases were excluded in this study. Clinical information, such as hypertension, diabetes, smoker, fasting serum levels of total cholesterol (TCH), triglyceride (TG), high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-cholesterol (LDL-C) and very low density lipoprotein-cholesterol (VLDL-C), was abstracted from the medical record review of our hospital. The controls were frequency matched to cases in terms of age and gender. All study subjects were unrelated Han Chinese.</p>
</sec>
<sec id="Sec11">
<title>DNA Extraction and Genotyping</title>
<p id="Par19">Blood samples from all subjects were collected in EDTA-containing tubes. Genomic DNA was isolated from peripheral blood mononuclear cells using a DNA extraction kit (QIANGEN, China) according to the manufacturer’s instructions and then stored at −70 °C for later use. Primer probes were designed using Primer Express Software (version 3.0) and synthesized and supplied by Applied Biosystems (United States). Primer sequences are presented in Table <xref ref-type="table" rid="Tab5">5</xref>. Genotyping was performed using SBE-PCR. The PCRs were performed in a total volume of 20 μL containing 3.0 mmol/L Mg<sup>2+</sup>, 0.3 mmol/L dNTP, 1 U HotStarTaq polymerase (QIANGEN, China), 1 μL genomic DNA, 1 μL PCR primer and 1× GC-I buffer (Takara). The PCR conditions included an initial denaturation step at 94 °C for 20 s, followed by 35 cycles with 20 s of denaturation at 94 °C, 30 s of annealing at 59 °C and 1.5 min of elongation at 72 °C, followed by a final elongation step of 72 °C for 2 min. PCR products were digested with Shrimp enzyme (SAP, from Promega) and excision enzyme (EXO I, from Epicentre). An ABI PRISM 3730XL analyser (PE Applied Biosystems, Foster City, CA, USA) sequenced the PCR products. The samples were reanalysed and verified by DNA sequencing if conflict results occurred. In addition, approximately 10% of all samples were randomly selected to be confirmed by DNA sequencing, and the results were 100% consistent.</p>
</sec>
<sec id="Sec12">
<title>Serum S100B determination</title>
<p id="Par20">Serum samples from IS patients and control subjects were separated from peripheral venous blood at room temperature and stored at −70 °C until use. The quantity determination of the levels of serum S100B was performed by ELISA kits (Human S100B, BioVendor, No: RD192090100R) following the manufacturer’s protocol. The developed colour reaction was measured as OD450 units on an ELISA reader (RT-6000, China). The concentration of serum S100B was determined using a standard curve constructed with the kit’s standards over the range of 10–320 pg/mL.</p>
</sec>
<sec id="Sec13">
<title>Statistical analysis</title>
<p id="Par21">All data were analysed with the software Statistical Package for Social Science (SPSS) for Windows, version 17.0 (SPSS, Inc., Chicago, USA). Hardy-Weinberg equilibrium (HWE) was tested by the chi-square test. Categorical variables were expressed as proportions and compared using the chi-squared test. Continuous variables were displayed the as mean ± SD. If the data were normally distributed, Student’s t-test was used; otherwise, the Mann-Whitney U test was used. The odds ratio (OR) and 95% confidence intervals (CI) were calculated to provide a measure of the strength of the <italic>S100B</italic> polymorphisms on IS risk. Logistic regression analysis was performed to estimate the putative association between the SNPs and the risk of IS while adjusting for age, sex, hypertension, diabetes, smoker, TCH, TG, HDL-L, LDL-L and VLDL-L. We carried out multiple hypothesis testing using the Benjamini-Hochberg method to control the false discovery rate (FDR) in the unconditional logistic regression analysis. Haplotype analysis was performed on an online tool SHEsis<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. Statistical significance was set at <italic>P</italic> &lt; 0.05.</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>Yu-Lan Lu and Rong Wang contributed equally to this work.</p>
</fn>
<fn>
<p><bold>Publisher's note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>This work was supported by the National Natural Science Foundation of China (No. 81560552; No. 81260234) and the Innovation project of Guangxi Graduate Education (NO. YCSW2017213).</p>
</ack>
<notes notes-type="author-contribution">
<title>Author Contributions</title>
<p>Yu-Lan Lu and Rong Wang designed and wrote the manuscript. Hua-Tuo Huang, Chun-Hong Liu and Hai-Mei Qin performed experiments. Chun-Fang Wang and Jun-Li Wang collected samples. Hong-Cheng Luo and Yang Xiang performed the statistical analysis and prepared the figure. Yan Lan and Ye-Sheng Wei conceived and designed the experiments. All authors read and approved the manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar1">
<title>Competing Interests</title>
<p id="Par22">The authors declare that they have no competing interests.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicholson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gandra</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Halbert</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Richhariya</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nordyke</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<article-title>Patient-level costs of major cardiovascular conditions: a review of the international literature</article-title>
<source/>ClinicoEconomics and outcomes research: CEOR
          <year>2016</year>
<volume>8</volume>
<fpage>495</fpage>
<lpage>506</lpage>
<pub-id pub-id-type="doi">10.2147/CEOR.S89331</pub-id>
<pub-id pub-id-type="pmid">27703385</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barker-Collo</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sex Differences in Stroke Incidence, Prevalence, Mortality and Disability-Adjusted Life Years: Results from the Global Burden of Disease Study 2013</article-title>
<source/>Neuroepidemiology
          <year>2015</year>
<volume>45</volume>
<fpage>203</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="doi">10.1159/000441103</pub-id>
<pub-id pub-id-type="pmid">26505984</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goljar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Burger</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Vidmar</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Leonardi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Marincek</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Measuring patterns of disability using the International Classification of Functioning, Disability and Health in the post-acute stroke rehabilitation setting</article-title>
<source/>Journal of rehabilitation medicine
          <year>2011</year>
<volume>43</volume>
<fpage>590</fpage>
<lpage>601</lpage>
<pub-id pub-id-type="doi">10.2340/16501977-0832</pub-id>
<pub-id pub-id-type="pmid">21603849</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>BF</given-names>
</name>
</person-group>
<article-title>Cardiovascular research is thriving in China</article-title>
<source/>British journal of pharmacology
          <year>2015</year>
<volume>172</volume>
<fpage>5430</fpage>
<lpage>5434</lpage>
<pub-id pub-id-type="doi">10.1111/bph.12826</pub-id>
<pub-id pub-id-type="pmid">24962428</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>An</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>BW</given-names>
</name>
</person-group>
<article-title>Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update</article-title>
<source/>Journal of stroke
          <year>2017</year>
<volume>19</volume>
<fpage>3</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.5853/jos.2016.00864</pub-id>
<pub-id pub-id-type="pmid">28178408</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hachiya</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic Predisposition to Ischemic Stroke: A Polygenic Risk Score</article-title>
<source/>Stroke; a journal of cerebral circulation
          <year>2017</year>
<volume>48</volume>
<fpage>253</fpage>
<lpage>258</lpage>
<pub-id pub-id-type="doi">10.1161/STROKEAHA.116.014506</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Munshi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kaul</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Genetic determinants in ischaemic stroke subtypes: seven year findings and a review</article-title>
<source/>Gene
          <year>2015</year>
<volume>555</volume>
<fpage>250</fpage>
<lpage>259</lpage>
<pub-id pub-id-type="doi">10.1016/j.gene.2014.11.015</pub-id>
<pub-id pub-id-type="pmid">25447900</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diaz-Romero</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nesic</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>S100A1 and S100B: Calcium Sensors at the Cross-Roads of Multiple Chondrogenic Pathways</article-title>
<source/>Journal of cellular physiology
          <year>2017</year>
<volume>232</volume>
<fpage>1979</fpage>
<lpage>1987</lpage>
<pub-id pub-id-type="doi">10.1002/jcp.25720</pub-id>
<pub-id pub-id-type="pmid">27925190</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamaguchi</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oxidative Stress Impairs the Stimulatory Effect of S100 Proteins on Protein Phosphatase 5 Activity</article-title>
<source/>The Tohoku journal of experimental medicine
          <year>2016</year>
<volume>240</volume>
<fpage>67</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1620/tjem.240.67</pub-id>
<pub-id pub-id-type="pmid">27600583</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bianchi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Giambanco</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Donato</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha</article-title>
<source/>Neurobiology of aging
          <year>2010</year>
<volume>31</volume>
<fpage>665</fpage>
<lpage>677</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2008.05.017</pub-id>
<pub-id pub-id-type="pmid">18599158</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niven</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>S100B Up-Regulates Macrophage Production of IL1beta and CCL22 and Influences Severity of Retinal Inflammation</article-title>
<source/>PloS one
          <year>2015</year>
<volume>10</volume>
<fpage>e0132688</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0132688</pub-id>
<pub-id pub-id-type="pmid">26204512</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salama</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hammad</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Risk Association between TNF-alpha-308 G &gt; A and IL-6-174 G/C Polymorphisms and Recurrent Transient Ischemic Attacks</article-title>
<source/>The Egyptian journal of immunology
          <year>2015</year>
<volume>22</volume>
<fpage>49</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="pmid">28502144</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wytrykowska</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Prosba-Mackiewicz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nyka</surname>
<given-names>WM</given-names>
</name>
</person-group>
<article-title>IL-1beta, TNF-alpha, and IL-6 levels in gingival fluid and serum of patients with ischemic stroke</article-title>
<source/>Journal of oral science
          <year>2016</year>
<volume>58</volume>
<fpage>509</fpage>
<lpage>513</lpage>
<pub-id pub-id-type="doi">10.2334/josnusd.16-0278</pub-id>
<pub-id pub-id-type="pmid">28025434</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Influence of the Cyclooxygenase-2 Gene −765G/C and −1195G/A Polymorphisms on Development of Ischemic Stroke</article-title>
<source/>Journal of stroke and cerebrovascular diseases: the official journal of National Stroke Association
          <year>2016</year>
<volume>25</volume>
<fpage>2126</fpage>
<lpage>2135</lpage>
<pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2016.06.001</pub-id>
<pub-id pub-id-type="pmid">27363623</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hennessy</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Griffin</surname>
<given-names>EW</given-names>
</name>
<name>
<surname>Cunningham</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Astrocytes Are Primed by Chronic Neurodegeneration to Produce Exaggerated Chemokine and Cell Infiltration Responses to Acute Stimulation with the Cytokines IL-1beta and TNF-alpha</article-title>
<source/>The Journal of neuroscience: the official journal of the Society for Neuroscience
          <year>2015</year>
<volume>35</volume>
<fpage>8411</fpage>
<lpage>8422</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2745-14.2015</pub-id>
<pub-id pub-id-type="pmid">26041910</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monson</surname>
<given-names>NL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Repetitive hypoxic preconditioning induces an immunosuppressed B cell phenotype during endogenous protection from stroke</article-title>
<source/>Journal of neuroinflammation
          <year>2014</year>
<volume>11</volume>
<fpage>22</fpage>
<pub-id pub-id-type="doi">10.1186/1742-2094-11-22</pub-id>
<pub-id pub-id-type="pmid">24485041</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>S100B and S100B autoantibody as biomarkers for early detection of brain metastases in lung cancer</article-title>
<source/>Translational lung cancer research
          <year>2016</year>
<volume>5</volume>
<fpage>413</fpage>
<lpage>419</lpage>
<pub-id pub-id-type="doi">10.21037/tlcr.2016.07.08</pub-id>
<pub-id pub-id-type="pmid">27652205</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chong</surname>
<given-names>ZZ</given-names>
</name>
<name>
<surname>Changyaleket</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dull</surname>
<given-names>RO</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>DE</given-names>
</name>
</person-group>
<article-title>Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases</article-title>
<source/>Current medicinal chemistry
          <year>2016</year>
<volume>23</volume>
<fpage>1571</fpage>
<lpage>1596</lpage>
<pub-id pub-id-type="doi">10.2174/0929867323666160406121117</pub-id>
<pub-id pub-id-type="pmid">27048377</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holla</surname>
<given-names>FK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis</article-title>
<source/>Journal of neuro-oncology
          <year>2016</year>
<volume>129</volume>
<fpage>525</fpage>
<lpage>532</lpage>
<pub-id pub-id-type="doi">10.1007/s11060-016-2204-z</pub-id>
<pub-id pub-id-type="pmid">27401156</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thelin</surname>
<given-names>EP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity</article-title>
<source/>Critical care (London, England)
          <year>2016</year>
<volume>20</volume>
<fpage>285</fpage>
<pub-id pub-id-type="doi">10.1186/s13054-016-1450-y</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<mixed-citation publication-type="other">Peng, Q. L. <italic>et al</italic>. Elevated levels of cerebrospinal fluid S100B are associated with brain injury and unfavorable outcomes in children with central nervous system infections. <italic>The International journal of neuroscience</italic>, 1–9, 10.3109/00207454.2015.1135334 (2016).</mixed-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lippi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cervellin</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Protein S100B: from cancer diagnostics to the evaluation of mild traumatic brain injury</article-title>
<source/>Clinical chemistry and laboratory medicine
          <year>2016</year>
<volume>54</volume>
<fpage>703</fpage>
<lpage>705</lpage>
<pub-id pub-id-type="pmid">27016152</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>S100beta as a biomarker for differential diagnosis of intracerebral hemorrhage and ischemic stroke</article-title>
<source/>Neurological research
          <year>2016</year>
<volume>38</volume>
<fpage>327</fpage>
<lpage>332</lpage>
<pub-id pub-id-type="doi">10.1080/01616412.2016.1152675</pub-id>
<pub-id pub-id-type="pmid">27078704</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanaka</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Marumo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shibuta</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Omura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Serum S100B, brain edema, and hematoma formation in a rat model of collagenase-induced hemorrhagic stroke</article-title>
<source/>Brain research bulletin
          <year>2009</year>
<volume>78</volume>
<fpage>158</fpage>
<lpage>163</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainresbull.2008.10.012</pub-id>
<pub-id pub-id-type="pmid">19027832</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagy</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Perioperative time course of matrix metalloproteinase-9 (MMP-9), its tissue inhibitor TIMP-1 &amp; S100B protein in carotid surgery</article-title>
<source/>The Indian journal of medical research
          <year>2016</year>
<volume>143</volume>
<fpage>220</fpage>
<lpage>226</lpage>
<pub-id pub-id-type="doi">10.4103/0971-5916.180212</pub-id>
<pub-id pub-id-type="pmid">27121520</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Isoflurane Post-Treatment Improves Outcome after an Embolic Stroke in Rabbits</article-title>
<source/>PloS one
          <year>2015</year>
<volume>10</volume>
<fpage>e0143931</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0143931</pub-id>
<pub-id pub-id-type="pmid">26645542</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seng</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Seng</surname>
<given-names>CK</given-names>
</name>
</person-group>
<article-title>The success of the genome-wide association approach: a brief story of a long struggle</article-title>
<source/>European journal of human genetics: EJHG
          <year>2008</year>
<volume>16</volume>
<fpage>554</fpage>
<lpage>564</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2008.12</pub-id>
<pub-id pub-id-type="pmid">18285837</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhai</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>S100B gene polymorphisms predict prefrontal spatial function in both schizophrenia patients and healthy individuals</article-title>
<source/>Schizophrenia research
          <year>2012</year>
<volume>134</volume>
<fpage>89</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1016/j.schres.2011.09.029</pub-id>
<pub-id pub-id-type="pmid">22019077</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsson</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Polymorphisms in DCDC2 and S100B associate with developmental dyslexia</article-title>
<source/>Journal of human genetics
          <year>2015</year>
<volume>60</volume>
<fpage>399</fpage>
<lpage>401</lpage>
<pub-id pub-id-type="doi">10.1038/jhg.2015.37</pub-id>
<pub-id pub-id-type="pmid">25877001</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egger</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of risk genes for autism spectrum disorder through copy number variation analysis in Austrian families</article-title>
<source/>Neurogenetics
          <year>2014</year>
<volume>15</volume>
<fpage>117</fpage>
<lpage>127</lpage>
<pub-id pub-id-type="doi">10.1007/s10048-014-0394-0</pub-id>
<pub-id pub-id-type="pmid">24643514</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roche</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Candidate gene analysis of 21q22: support for S100B as a susceptibility gene for bipolar affective disorder with psychosis</article-title>
<source/>American journal of medical genetics. Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics
          <year>2007</year>
<volume>144B</volume>
<fpage>1094</fpage>
<lpage>1096</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.30556</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feigin</surname>
<given-names>VL</given-names>
</name>
<name>
<surname>Norrving</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Mensah</surname>
<given-names>GA</given-names>
</name>
</person-group>
<article-title>Global Burden of Stroke</article-title>
<source/>Circulation research
          <year>2017</year>
<volume>120</volume>
<fpage>439</fpage>
<lpage>448</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.308413</pub-id>
<pub-id pub-id-type="pmid">28154096</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selcuk</surname>
<given-names>O</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Relationship of Serum S100B Levels with Infarction Size and Clinical Outcome in Acute Ischemic Stroke Patients</article-title>
<source/>Noro psikiyatri arsivi
          <year>2014</year>
<volume>51</volume>
<fpage>395</fpage>
<lpage>400</lpage>
<pub-id pub-id-type="doi">10.5152/npa.2014.7213</pub-id>
<pub-id pub-id-type="pmid">28360660</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Serum S100B levels may be associated with cerebral infarction: a meta-analysis</article-title>
<source/>Journal of the neurological sciences
          <year>2015</year>
<volume>348</volume>
<fpage>81</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1016/j.jns.2014.11.010</pub-id>
<pub-id pub-id-type="pmid">25434713</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ichijo</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Significance of Development and Reversion of Collaterals on MRI in Early Neurologic Improvement and Long-Term Functional Outcome after Intravenous Thrombolysis for Ischemic Stroke</article-title>
<source/>AJNR. American journal of neuroradiology
          <year>2015</year>
<volume>36</volume>
<fpage>1839</fpage>
<lpage>1845</lpage>
<pub-id pub-id-type="doi">10.3174/ajnr.A4384</pub-id>
<pub-id pub-id-type="pmid">26206807</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hohoff</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Risk variants in the S100B gene predict elevated S100B serum concentrations in healthy individuals</article-title>
<source/>American journal of medical genetics. Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics
          <year>2010</year>
<volume>153b</volume>
<fpage>291</fpage>
<lpage>297</lpage>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>[Association between S100B gene polymorphisms and hand, foot and mouth disease caused by enterovirus 71 infection]</article-title>
<source/>Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
          <year>2017</year>
<volume>19</volume>
<fpage>904</fpage>
<lpage>907</lpage>
<pub-id pub-id-type="pmid">28774366</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>SNPs and haplotypes in the S100B gene reveal association with schizophrenia</article-title>
<source/>Biochemical and biophysical research communications
          <year>2005</year>
<volume>328</volume>
<fpage>335</fpage>
<lpage>341</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2004.12.175</pub-id>
<pub-id pub-id-type="pmid">15670788</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>YQ</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>FQ</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>LY</given-names>
</name>
</person-group>
<article-title>Association study of astrocyte-derived protein S100B gene polymorphisms with major depressive disorder in Chinese people</article-title>
<source/>Canadian journal of psychiatry. Revue canadienne de psychiatrie
          <year>2009</year>
<volume>54</volume>
<fpage>312</fpage>
<lpage>319</lpage>
<pub-id pub-id-type="doi">10.1177/070674370905400505</pub-id>
<pub-id pub-id-type="pmid">19497163</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic analysis of the S100B gene in Chinese patients with Parkinson disease</article-title>
<source/>Neuroscience letters
          <year>2013</year>
<volume>555</volume>
<fpage>134</fpage>
<lpage>136</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2013.09.037</pub-id>
<pub-id pub-id-type="pmid">24076007</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sorci</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>S100B protein in tissue development, repair and regeneration</article-title>
<source/>World journal of biological chemistry
          <year>2013</year>
<volume>4</volume>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.4331/wjbc.v4.i1.1</pub-id>
<pub-id pub-id-type="pmid">23580916</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reddy</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells</article-title>
<source/>The Journal of biological chemistry
          <year>2006</year>
<volume>281</volume>
<fpage>13685</fpage>
<lpage>13693</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M511425200</pub-id>
<pub-id pub-id-type="pmid">16551628</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>S100B attenuates microglia activation in gliomas: possible role of STAT3 pathway</article-title>
<source/>Glia
          <year>2011</year>
<volume>59</volume>
<fpage>486</fpage>
<lpage>498</lpage>
<pub-id pub-id-type="doi">10.1002/glia.21118</pub-id>
<pub-id pub-id-type="pmid">21264954</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozkan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Silan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Uludag</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Degirmenci</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ozisik Karaman</surname>
<given-names>HI</given-names>
</name>
</person-group>
<article-title>Tumour necrosis factor alpha, interleukin 10 and interleukin 6 gene polymorphisms of ischemic stroke patients in south Marmara region of Turkey</article-title>
<source/>International journal of clinical and experimental pathology
          <year>2015</year>
<volume>8</volume>
<fpage>13500</fpage>
<lpage>13504</lpage>
<pub-id pub-id-type="pmid">26722564</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tumor necrosis factor-alpha (−308G/A, +488G/A, −857C/T and −1031 T/C) gene polymorphisms and risk of ischemic stroke in north Indian population: A hospital based case-control study</article-title>
<source/>Meta gene
          <year>2016</year>
<volume>7</volume>
<fpage>34</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="doi">10.1016/j.mgene.2015.11.003</pub-id>
<pub-id pub-id-type="pmid">26862479</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>S100B promotes injury-induced vascular remodeling through modulating smooth muscle phenotype</article-title>
<source/>Biochimica et biophysica acta
          <year>2017</year>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Blacker</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bynevelt</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hankey</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Puddey</surname>
<given-names>IB</given-names>
</name>
</person-group>
<article-title>Systemic markers of inflammation are independently associated with S100B concentration: results of an observational study in subjects with acute ischaemic stroke</article-title>
<source/>Journal of neuroinflammation
          <year>2010</year>
<volume>7</volume>
<fpage>71</fpage>
<pub-id pub-id-type="doi">10.1186/1742-2094-7-71</pub-id>
<pub-id pub-id-type="pmid">21034449</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mori</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Overexpression of human S100B exacerbates brain damage and periinfarct gliosis after permanent focal ischemia</article-title>
<source/>Stroke; a journal of cerebral circulation
          <year>2008</year>
<volume>39</volume>
<fpage>2114</fpage>
<lpage>2121</lpage>
<pub-id pub-id-type="doi">10.1161/STROKEAHA.107.503821</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tokuno</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Spontaneous ischemic events in the brain and heart adapt the hearts of severely atherosclerotic mice to ischemia</article-title>
<source/>Arteriosclerosis, thrombosis, and vascular biology
          <year>2002</year>
<volume>22</volume>
<fpage>995</fpage>
<lpage>1001</lpage>
<pub-id pub-id-type="doi">10.1161/01.ATV.0000017703.87741.12</pub-id>
<pub-id pub-id-type="pmid">12067910</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>He</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci</article-title>
<source/>Cell research
          <year>2005</year>
<volume>15</volume>
<fpage>97</fpage>
<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1038/sj.cr.7290286</pub-id>
<pub-id pub-id-type="pmid">15740637</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>